Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 January 1996 | Volume 124 Issue 1 Part 2 | Pages 127-130
Purpose: To review population-based studies that investigated the association and nature of association between glycemic control and the risk for coronary heart disease in patients with noninsulin-dependent diabetes mellitus (NIDDM).
Data Sources: Study 1 included 133 newly diagnosed patients with NIDDM from eastern Finland, who were 45 to 64 years of age at baseline. These patients were followed up to 10 years for cardiovascular mortality. Study 2 included 229 newly or previously diagnosed patients with NIDDM from eastern Finland, aged 65 to 74 years at baseline. These patients were followed up to 3.5 years for coronary heart disease mortality and all coronary heart disease events (mortality or nonfatal myocardial infarction).
Study Selection: Prospective, population-based studies that included indicators of glycemic control and the evaluation of coronary heart disease and cardiovascular risk.
Results: Study 1: 10-year cardiovascular mortality was significantly and linearly associated with glycemic control (fasting blood glucose and glycated hemoglobin A1 levels) independently of the mode of treatment. A high fasting blood glucose level significantly predicted cardiovascular mortality in multiple logistic regression analysis independently of other risk factors. Study 2: Glycated hemoglobin A1c was the most important single risk factor associated with coronary heart disease death or all coronary heart disease events. In multiple logistic regression analysis, glycated hemoglobin A1c was significantly associated with coronary heart disease death after adjustment for other cardiovascular risk factors.
Conclusions: Two prospective, population-based studies from Finland give evidence for the linear association of glycemic control with the risk for coronary heart disease in middle-aged and elderly patients with NIDDM.
Author and Article Information
From the University of Kuopio, Finland. For the current author address, see end of text.
ONGOING AND PROPOSED TRIALS
Glycemic Control and the Risk for Coronary Heart Disease in Patients with Non-Insulin-dependent Diabetes Mellitus: The Finnish Studies
![]()
Note: This article is one of a series of articles comprising an Annals of Internal Medicine supplement entitled "Risks and Benefits of Intensive Management in Non-Insulin-dependent Diabetes Mellitus: The Fifth Regenstrief Conference." To view a complete list of the articles included in this supplement, please view its Table of Contents.
Grant Support: From the Medical Research Council of the Academy of Finland.
Requests for Reprints: Markku Laakso, MD, Department of Medicine, University of Kuopio 70210, Kuopio, Finland.
This article has been cited by other articles:
![]() |
C. Bianchi, R. Miccoli, G. Penno, and S. Del Prato Primary Prevention of Cardiovascular Disease in People With Dysglycemia Diabetes Care, February 1, 2008; 31(Supplement_2): S208 - S214. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Nielson, T. Lange, and N. Hadjokas Blood Glucose and Coronary Artery Disease in Nondiabetic Patients Diabetes Care, May 1, 2006; 29(5): 998 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Lau, M. Journoud, and P. J. Jones Plant sterols are efficacious in lowering plasma LDL and non-HDL cholesterol in hypercholesterolemic type 2 diabetic and nondiabetic persons Am. J. Clinical Nutrition, June 1, 2005; 81(6): 1351 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schillinger, M. Exner, J. Amighi, W. Mlekusch, S. Sabeti, H. Rumpold, O. Wagner, and E. Minar Joint Effects of C-Reactive Protein and Glycated Hemoglobin in Predicting Future Cardiovascular Events of Patients With Advanced Atherosclerosis Circulation, November 11, 2003; 108(19): 2323 - 2328. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vijan and R. A. Hayward Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care Ann Intern Med, April 1, 2003; 138(7): 593 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J Krentz Type 2 diabetes and atherosclerotic cardiovascular disease: do they share common antecedents? The British Journal of Diabetes & Vascular Disease, September 1, 2002; 2(5): 370 - 378. [Abstract] [PDF] |
||||
![]() |
E. M. Benjamin Case Study: Glycemic Control in the Elderly: Risks and Benefits Clin. Diabetes, July 1, 2002; 20(3): 118 - 121. [Full Text] [PDF] |
||||
![]() |
R. S. Surwit, R. B. Williams, I. C. Siegler, J. D. Lane, M. Helms, K. L. Applegate, N. Zucker, M. N. Feinglos, C. M. McCaskill, and J. C. Barefoot Hostility, Race, and Glucose Metabolism in Nondiabetic Individuals Diabetes Care, May 1, 2002; 25(5): 835 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Tenerz, I Lonnberg, C Berne, G Nilsson, and J Leppert Myocardial infarction and prevalence of diabetes mellitus. Is increased casual blood glucose at admission a reliable criterion for the diagnosis of diabetes? Eur. Heart J., July 1, 2001; 22(13): 1102 - 1110. [Abstract] [PDF] |
||||
![]() |
C. Iribarren, A. J. Karter, A. S. Go, A. Ferrara, J. Y. Liu, S. Sidney, and J. V. Selby Glycemic Control and Heart Failure Among Adult Patients With Diabetes Circulation, June 5, 2001; 103(22): 2668 - 2673. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Hiss, M. L. Gillard, B. A. Armbruster, and L. A. McClure Comprehensive Evaluation of Community-Based Diabetic Patients: Effect of feedback to patients and their physicians: a randomized controlled trial Diabetes Care, April 1, 2001; 24(4): 690 - 694. [Abstract] [Full Text] |
||||
![]() |
N Kawakami, K Akachi, H Shimizu, T Haratani, F Kobayashi, M Ishizaki, T Hayashi, O Fujita, Y Aizawa, S Miyazaki, et al. Job strain, social support in the workplace, and haemoglobin A1c in Japanese men Occup. Environ. Med., December 1, 2000; 57(12): 805 - 809. [Abstract] [Full Text] |
||||
![]() |
R. A. Rajaratnam, H. Gylling, and T. A. Miettinen Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1185 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W Anderson, L. D Allgood, J. Turner, P. R Oeltgen, and B. P Daggy Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia Am. J. Clinical Nutrition, October 1, 1999; 70(4): 466 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Poor Glycemic Control Predicts Coronary Heart Disease Events in Patients With Type 1 Diabetes Without Nephropathy Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 1014 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muggeo, G. Verlato, E. Bonora, G. Zoppini, M. Corbellini, and R. de Marco Long-term Instability of Fasting Plasma Glucose, a Novel Predictor of Cardiovascular Mortality in Elderly Patients With Non–Insulin-Dependent Diabetes Mellitus : The Verona Diabetes Study Circulation, September 16, 1997; 96(6): 1750 - 1754. [Abstract] [Full Text] |
||||
![]() |
T. B. Investigators Influence of Diabetes on 5-Year Mortality and Morbidity in a Randomized Trial Comparing CABG and PTCA in Patients With Multivessel Disease : The Bypass Angioplasty Revascularization Investigation (BARI) Circulation, September 16, 1997; 96(6): 1761 - 1769. [Abstract] [Full Text] |
||||